FDA Biosimilar Action Plan: could improving...

FDA Biosimilar Action Plan: could improving pharmacovigilance of biologics improve patient and physician confidence in biosimilars?

Jordan, John B, Christl, Leah
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Opinion on Drug Safety
DOI:
10.1080/14740338.2020.1733966
Date:
February, 2020
File:
PDF, 880 KB
english, 2020
Conversion to is in progress
Conversion to is failed